- Press Release Distribution

Researchers: HtrA1 augmentation is potential therapy for age-related macular degeneration

Researchers: HtrA1 augmentation is potential therapy for age-related macular degeneration
( Research conducted at the Sharon Eccles Steele Center for Translational Medicine (SCTM) at the University of Utah's John A. Moran Eye Center explains why people carrying a block of genetic variants strongly associated with the development of age-related macular degeneration (AMD) may develop the disease and identifies a potential therapeutic pathway for slowing or even reversing disease progression.

AMD is a major cause of irreversible blindness worldwide and the leading cause of blindness for Americans aged 55 and over. Following more than 15 years of research that has employed an extensive repository of donated human ocular tissues, scientists found that HtrA1 protein normally increases with age in the eye at the retinal pigmented epithelium (RPE)-Bruch's membrane interface, helping to maintain the normal function of this region. The RPE is a cell layer that delivers nutrients to and removes waste from the retina's light-sensitive photoreceptor cells.

These new data show this is not the case in individuals with AMD-associated risk variants located on chromosome 10. These variants were found to impair expression of the HTRA1 gene by the RPE, resulting in an approximately 50 percent reduction of HtrA1 protein levels at the RPE-Bruch's membrane interface during aging. The failure to produce adequate levels of HtrA1 protein disrupts this key region of the eye and is associated with AMD-associated pathologies, including the deposition of abnormal deposits and the development of abnormal blood vessels.

These findings, coming from the laboratory of SCTM Executive Director Gregory S. Hageman, PhD, represent the first explanation of the essential role of HtrA1 in maintaining ocular health and contradict literature previously published by others. They are anticipated to inform the development of novel therapies for chromosome 10-directed AMD.

These research data will appear the week of July 19, 2021, in the Proceedings of the National Academy of Sciences of the United States of America (PNAS): "Chromosome 10q26-Driven Age-related Macular Degeneration is Associated with Reduced Levels of HTRA1 in Human Retinal Pigment Epithelium."

Lead author Brandi L. Williams, PhD, said her team found significantly reduced levels of HTRA1 messenger ribonucleic acid (mRNA) in the RPE and secreted HtrA1 protein at the RPE-Bruch's membrane interface. Reduced HTRA1 expression was found to be risk allele-specific, but only in the RPE and not in the neural retina or choroid. Notably, the team also narrowed a large genetic region of AMD-associated chromosome 10 to a much smaller causal region, which likely directs the reduced expression of HTRA1.

"Our findings are significant because they suggest that HtrA1 normally maintains the integrity of the RPE-Bruch's membrane interface during the aging process by, in essence, turning over extracellular material and preventing abnormal deposits--including basal laminar deposits--from accumulating between the RPE and Bruch's membrane," said Williams. "Earlier unpublished SCTM studies documented a significant association between chromosome 10 and the formation of basal laminar deposits. Viewing HtrA1 as protective runs contrary to what one might expect because elevation of HtrA1 protein is thought to be a contributing factor in some diseases such as osteoarthritis."

Access to a unique repository of more than 8,000 pairs of donated human eyes was essential to this study since there are no animal models that accurately mimic the biology of chromosome 10-directed AMD. This critical resource allowed the SCTM team to compare HTRA1 expression in eyes derived from donors with and without chromosome 10-associated risk genotypes.

"We were able to generate these exciting results thanks to our eye donors and their families," said Hageman. "We are so extremely grateful for their precious gifts."

The SCTM team conducted a number of difficult and time-consuming experiments to reach their groundbreaking conclusions, which contradict previously published literature reporting either no difference or elevated levels of HtrA1 in human ocular tissues or blood. Hageman pointed out that "those particular studies employed too few samples and the analyses were performed using neural retina and white blood cells, rather than RPE-Bruch's membrane, which is the primary site of AMD pathogenesis."

"Unfortunately, data generated by prior studies have led to the development and testing of therapies--some of which are currently in human clinical trials--designed to reduce overall levels of HtrA1, an approach that may exacerbate AMD progression," said Hageman. "Our team has been tireless in its pursuit of accuracy, conducting many extremely difficult experiments to generate these data. They persevered year after year, and I couldn't be more excited about the data and the scientific acumen of this talented team."

Williams said the research will have a broad impact.

"These data should be important to the entire field and to patients with this devastating disease," she said, "especially in light of developing therapeutic technologies to correct genes by excising the defected region and repairing it."

SCTM scientists and clinicians are now focused on the development of a therapy for chromosome 10-directed AMD. They have also developed a potential therapy for individuals at risk for AMD due to abnormal genes lying on chromosome 1. Together, chromosomes 1 and 10 account for more than 50 percent of genetic risk for developing AMD.

This is Hageman's second publication in PNAS related to the major genetic underpinnings of AMD. In 2005, a landmark paper revealed that genetic variants and haplotypes in the Complement Factor H and related genes on chromosome 1 predispose individuals to AMD.

"When Dr. Hageman started his AMD-related research nearly 30 years ago, he was a marine biologist who decided to shift gears and investigate AMD at a time when this horrible, blinding disease was simply accepted as something no one could do anything about," said Randall J Olson, MD, Moran Eye Center CEO and Distinguished Professor of Ophthalmology and Visual Sciences. "He didn't accept that. I didn't accept that. Thus, we created the SCTM as a unique academic model designed to quickly turn discoveries into therapies through partnerships with philanthropists and industry as well as national and international scientific collaborators."

A major gene expression study conducted as part of a research and development collaboration with Allergan in 2014 employed various ocular tissues and blood cells from over 700 donors and patients, generated about 9.2 billion data points, and revealed new insights relating to the biology of gene-directed AMD.

"It's clear our approach is working," said Olson, "and that Dr. Hageman and his team have greatly advanced and continue to advance our knowledge about AMD and to develop treatments for it."


The SCTM team of authors are: Brandi L. Williams, Nathan A. Seager, Jamie D. Gardiner, Chris M. Pappas, Monica C. Cronin, Cristina Amat di San Filippo, Robert A. Anstadt, Jin Liu, Marc A. Toso, Lisa Nichols, Timothy J. Parnell, Jacqueline R. Eve, Paul L. Bartel, Moussa A. Zouache, Burt T. Richards, and Gregory S. Hageman.

The research was supported in part by grants from the National Institutes of Health (R01 EY014800, R24 EY017404); charitable donations made to the Sharon Eccles Steele Center for Translational Medicine; and an unrestricted grant from Research to Prevent Blindness, New York, NY, to the Department of Ophthalmology and Visual Sciences, University of Utah.

Media Contact:
Elizabeth Neff
801-585-3730 (office)

Learn more about the SCTM at

About the John A. Moran Eye Center
The John A. Moran Eye Center at the University of Utah serves as the largest ophthalmology clinical care and research facility in the Mountain West, with more than 60 faculty members and 10 satellite clinics. Physicians provide comprehensive care in all ophthalmic subspecialties, making the Moran Eye Center a major referral center for complex cases with over 145,000 patient visits and about 7,000 surgeries annually. Moran supports 15 research laboratories, and its Sharon Eccles Steele Center for Translational Medicine works to turn lab discoveries into therapies quickly through public-private partnerships. CEO and Distinguished Professor of Ophthalmology and Visual Sciences Randall J Olson, MD, leads more than 500 employees working to achieve the Moran Eye Center's vision that no person with a blinding condition, eye disease, or visual impairment should be without hope, understanding, and treatment.

[Attachments] See images for this press release:
Researchers: HtrA1 augmentation is potential therapy for age-related macular degeneration


Global satellite data shows clouds will amplify global heating

A new approach to analyse satellite measurements of Earth's cloud cover reveals that clouds are very likely to enhance global heating. The research, by scientists at Imperial College London and the University of East Anglia, is the strongest evidence yet that clouds will amplify global heating over the long term, further exacerbating climate change. The results, published today in Proceedings of the National Academy of Sciences, also suggest that at double atmospheric carbon dioxide (CO2) concentrations above pre-industrial levels, the climate is unlikely to warm below 2°C, and is more likely on average to warm more than 3°C. Pre-industrial CO2 levels were around 280 ppm (parts per million), ...

Using archeology to better understand climate change

Throughout history, people of different cultures and stages of evolution have found ways to adapt, with varying success, to the gradual warming of the environment they live in. But can the past inform the future, now that climate change is happening faster than ever before? Yes, say an international team of anthropologists, geographers and earth scientists in Canada, the U.S. and France led by Université de Montréal anthropologist Ariane Burke. In a paper published today in the Proceedings of the National Academy of Sciences, Professor Burke and her colleagues ...

Epicentre of major Amazon droughts and fires saw 2.5 billion trees and vines killed

Epicentre of major Amazon droughts and fires saw 2.5 billion trees and vines killed
A major drought and forest fires in the Amazon rainforest killed billions of trees and plants and turned one of the world's largest carbon sinks into one of its biggest polluters. Triggered by the 2015-16 El Niño, extreme drought and associated mega-wildfires caused the death of around 2.5 billion trees and plants and emitted 495 million tonnes of CO2 from an area that makes up just 1.2 per cent of the entire Brazilian Amazon rainforest, and 1 per cent of the whole biome. The stark findings, discovered by an international team of scientists working for more than eight years on a long-term study in the Amazon before, during and after the El Niño, have significant implications for global efforts to control the atmospheric ...

Stanford researchers use high-speed cameras to reveal bubbles popping like blooming flowers

Stanford researchers use high-speed cameras to reveal bubbles popping like blooming flowers
The oil industry, pharmaceutical companies and bioreactor manufacturers all face one common enemy: bubbles. Bubbles can form during the manufacturing or transport of various liquids, and their formation and rupture can cause significant issues in product quality. Inspired by these issues and the puzzling physics behind bubbles, an international scientific collaboration was born. Stanford University chemical engineer Gerald Fuller along with his PhD students Aadithya Kannan and Vinny Chandran Suja, as well as visiting PhD student Daniele Tammaro from the University of Naples, teamed up to study how different kinds of bubbles pop. The researchers were particularly interested in bubbles with proteins embedded on their surfaces, which is a common occurrence in the pharmaceutical industry ...

Seismic surveys have no significant impact on commercially valuable fish in NW Australia

Seismic surveys have no significant impact on commercially valuable fish in NW Australia
New research has found marine seismic surveys used in oil and gas exploration are not impacting the abundance or behaviour of commercially valuable fishes in the tropical shelf environment in north-western Australia. The research is the first of its kind to use dedicated seismic vessels to measure the impacts of the survey's noise in an ocean environment, with the eight-month experiment conducted within a 2500 square kilometre fishery management zone near the Pilbara coast. It involved using multiple acoustic sensors, tagging 387 red emperor fish and deploying more than ...

CNIO researchers clarify the role of the two isoforms of KRAS, the most common oncogene in humans

CNIO researchers clarify the role of the two isoforms of KRAS, the most common oncogene in humans
KRAS was one of the first oncogenes to be identified, a few decades ago. It is among the most common drivers of cancer and its mutations can be detected in around 25 per cent of human tumours. The development of KRAS inhibitors is, thus, an extremely active line of research. Effective results have been elusive so far, though - no KRAS inhibitor had been available until a month ago, when the FDA granted approval to Sotorasib. KRAS encodes two gene products, KRAS4A and KRAS4B, whose levels can vary across organs and embryonic stages. When KRAS mutates, both variants, or isoforms, are activated. Though, some studies have focussed on approaches to target only KRAS4B, since it usually found to be expressed at ...

Program seeks to reduce preventable cancers with free screening, same-day results

Evidence shows that early detection and treatment of cancer can significantly improve health outcomes, however women in Mississippi, particularly in underserved populations, experience the worst health outcomes for cervical, breast, and oropharyngeal cancer. ...

Of lives and life years: 1918 influenza vs COVID-19

Of lives and life years: 1918 influenza vs COVID-19
From the onset of the COVID-19 pandemic there have been countless comparisons to the 1918 influenza pandemic in terms of overall medical impact. Many of the comparisons addressed overall cases which, given the lack of a confirmatory lab test in 1918 and no meaningful case definitions for both pandemics, make such comparisons patently invalid. Overall mortality comparisons, although methodologically flawed as well, do offer a reasonably comparative outcome measure and offers a greater degree of validity. This measure is further enhanced when adjusted for population and average life years lost (see accompanying table for mortality comparisons ...

Novel autoantibody adds fuel to COVID-19 'firestorm' of inflammation, blood clots

Researchers at Michigan Medicine have discovered yet another functional autoantibody in COVID-19 patients that contributes to the disease's development and the "firestorm" of blood clots and inflammation it induces. A growing body of studies suggests COVID-19 emulates many aspects of systemic autoimmune disorders, including the release of a flurry of overactive immune cells that produce toxic webs of proteins and DNA called neutrophil extracellular traps, or NETs. For this study, the team analyzed serum from over 300 hospitalized COVID patients, searching for a novel autoantibody that shields the toxic NETs from being destroyed and produces a lasting ...

New study examines commuter characteristics and traffic pollution exposure among commuters

The link between on-road traffic and air pollution is well-known, as are the negative health impacts of pollution exposure. However, the many factors that may influence commuters' exposure to pollutants - such as frequency, time, and duration of commute - and the overall impact of commuting remains a matter of on-going scientific discovery. Dr. Jenna Krall, assistant professor at the George Mason University College of Health and Human Services, is using statistical methods to better understand exposure to air pollution. Krall studies how commuting patterns impact exposure to fine particulate matter ...


Scientists model 'true prevalence' of COVID-19 throughout pandemic

New breakthrough to help immune systems in the fight against cancer

Through the thin-film glass, researchers spot a new liquid phase

Administering opioids to pregnant mice alters behavior and gene expression in offspring

Brain's 'memory center' needed to recognize image sequences but not single sights

Safety of second dose of mRNA COVID-19 vaccines after first-dose allergic reactions

Changes in disparities in access to care, health after Medicare eligibility

Use of high-risk medications among lonely older adults

65+ and lonely? Don't talk to your doctor about another prescription

Exosome formulation developed to deliver antibodies for choroidal neovascularization therapy

Second COVID-19 mRNA vaccine dose found safe following allergic reactions to first dose

Plant root-associated bacteria preferentially colonize their native host-plant roots

Rare inherited variants in previously unsuspected genes may confer significant risk for autism

International experts call for a unified public health response to NAFLD and NASH epidemic

International collaboration of scientists rewrite the rulebook of flowering plant genetics

Improving air quality reduces dementia risk, multiple studies suggest

Misplaced trust: When trust in science fosters pseudoscience

Two types of blood pressure meds prevent heart events equally, but side effects differ

New statement provides path to include ethnicity, ancestry, race in genomic research

Among effective antihypertensive drugs, less popular choice is slightly safer

Juicy past of favorite Okinawan fruit revealed

Anticipate a resurgence of respiratory viruses in young children

Anxiety, depression, burnout rising as college students prepare to return to campus

Goal-setting and positive parent-child relationships reduce risk of youth vaping

New research identifies cancer types with little survival improvements in adolescents and young adul

Oncotarget: Replication-stress sensitivity in breast cancer cells

Oncotarget: TERT and its binding protein: overexpression of GABPA/B in gliomas

Development of a novel technology to check body temperature with smartphone camera

The mechanics of puncture finally explained

Extreme heat, dry summers main cause of tree death in Colorado's subalpine forests

[] Researchers: HtrA1 augmentation is potential therapy for age-related macular degeneration